Fairchem Organics Limited

Fairchem Organics Limited

FAIRCHEMOR.BO
Fairchem Organics LimitedIN flagBombay Stock Exchange
704.25
INR
-2.75
- -
8.39BMarket Cap
Fairchem Organics Limited
FAIRCHEMOR.BO
(Bombay Stock Exchange)

Recent

price

704.25

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
2025
2026
TTM
FRC
235.56
303.97
493.27
496.38
474.86
411.87
354.49
347.21
Revenue per Share
26.73
32.63
52.15
33.41
31.1
16.88
4.28
4.19
Basic EPS, GAAP
0.65
12.64
4.52
26.79
43.28
-32.94
20.29
- -
Free Cash Flow per Basic Share
8.08
- -
3.5
13
7.5
7.5
7.55
- -
Dividend per Share
18.58
60.79
109.49
130.31
153.87
163.16
133.72
130.71
Book Value per Share
97.56
129.55
178.09
198.71
222.4
231.84
203.25
198.67
Tangible Book Value per Share
13
13
13
13
13
13
13
13
Basic Weighted Avg Shares
3,058
3,958
6,423
6,463
6,183
5,363
4,587
4,596
Sales/Revenue/Turnover
13.97
15.73
15.23
9.94
9.33
6.08
2.31
2.3
Operating Margin (%)
60
66
71
82
93
105
110
110
Depreciation Expense
347
425
679
435
405
220
55
55
Net Income, GAAP
18.19
23.53
25.57
25.76
25.82
26.56
24.31
24.31
Effective Tax Rate (%)
11.35
10.73
10.57
6.73
6.55
4.1
1.21
1.21
Profit Margin (%)
118
471
699
818
1,068
1,020
676
676
Working Capital
163
260
100
- -
- -
- -
- -
- -
LT Debt
1,267
1,687
2,321
2,593
2,899
3,020
2,630
2,630
Total Equity
- -
22.53
27.87
15.77
14.1
7.24
2.25
2.25
Return on Invested Capital (%)
- -
42.18
42.88
22.69
20.42
10.21
3.13
3.13
Return on Capital (%)
- -
82.28
61.25
27.86
21.89
10.65
2.87
2.87
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
544
- -
838
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
- -
13
Market Capitalization
10,064
9,585
5,739

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
1,599
- -
1,719
Cash, Cash Equivalents & STI
13
- -
11
Accounts Receivable, Net
625
- -
681
Inventories
883
- -
923
Total Current Liabilities
724
- -
1,043
Payables & Accruals
- -
- -
- -
ST Debt
544
- -
838
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
10.47%
-12.91%
Free Cash Flow
- -
30.43%
-161.23%
Net Income, GAAP
- -
-20.71%
-74.79%
Sales/Revenue/Turnover
- -
6.17%
-14.46%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,606
1,522
1,481
1,584
6,183
2025
1,649
1,386
1,136
1,208
5,363
2026
1,311
1,115
1,001
1,169
4,587

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4.7
7.9
9.47
- -
31.1
2025
10.64
3.08
2.7
0.46
16.88
2026
0.9
0.59
-0.07
2.85
4.28

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
7.5
2025
- -
- -
- -
- -
7.5
2026
- -
- -
- -
- -
7.55
Business
Fairchem Organics Limited is an Indian specialty chemicals company primarily engaged in the manufacturing of oleo chemicals and nutraceutical intermediates. The company's main products include dimer acid, linoleic acid, palmitic acid, monomer acid, isostearic acid, mixed tocopherol concentrate, and sterols concentrate, which serve diverse industries such as nutraceuticals, paints, printing inks, detergents, adhesives, personal care, cosmetics, and bio-degradable products. Fairchem sources raw materials mainly from waste generated in vegetable oil refining mills, processing these into high-value fatty acids and related chemicals. It is one of the only manufacturers of linoleic acid and dimer acid in India. The company operates primarily in the Indian market while also exporting some products internationally. Founded in 2019 following the demerger from Fairchem Speciality Limited, Fairchem Organics is headquartered in Mumbai, India. In the last 1-2 years, Fairchem has commercialized isostearic acid, targeting personal care and cosmetics applications, expanding its product portfolio beyond its traditional oleo chemical base. The company is currently pursuing a share buyback plan approved by its board in late 2025 aimed at enhancing shareholder value. Despite some challenges reflected in a recent quarter with a decline in net profit and revenue, Fairchem continues to focus on scaling its operations and diversifying its revenue streams through innovation and new product introductions. The company reported operating income exceeding ₹750 crore in the recent fiscal year, with healthy margins on a sustained basis, emphasizing growth in specialty chemicals and nutraceutical segments. Fairchem’s product mix includes specialty fatty acids like dimer acid, palmitic acid, linoleic acid, isostearic acid; nutraceutical ingredients such as mixed tocopherol concentrate; and bio-based chemical intermediates used extensively across FMCG, pharmaceutical, feed, paints, and adhesives industries. The company has developed cutting-edge processing techniques to extract and purify these chemicals from renewable natural oils and fats including soya, sunflower, corn, rice bran, and rape seed oil derivatives. Recent strategic focus includes expanding the isostearic acid product line and enhancing operational efficiencies to address competitive pressures and market demand fluctuations. Fairchem Organics Limited operates as a standalone entity following its 2019 spin-off and continues to leverage its parent’s legacy in specialty chemicals manufacturing while advancing new product development. Its strategic initiatives over the past two years highlight a commitment to sustainability by converting vegetable oil refining wastes into value-added specialty chemical products, positioning the company as a leading domestic producer in its niche oleochemical categories. Overall, Fairchem Organics presents a focused specialty chemical and nutraceutical intermediary company with strong capabilities in producing high-value fatty acids and related products for domestic and international markets, alongside ongoing efforts to expand product offerings and optimize shareholder returns through recent buyback proposals. The company remains headquartered in Mumbai, India.